Earnings Feed
Start Free
Home/Filings/4/0001079974-15-000257
4//SEC Filing

OMNI BIO PHARMACEUTICAL, INC. 4

Accession 0001079974-15-000257

CIK 0001389870operating
View on SEC.govCompany Profile

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 6:10 PM ET

Size

13.0 KB

Accession

0001079974-15-000257

Insider Transaction Report

Form 4
Period: 2014-04-25
OMNI BIO PHARMACEUTICAL, INC.OMBP
Bohemian Investments LLC
10% Owner
Transactions
  • Purchase

    Convertible Note

    2014-12-12$500000.00/sh+2,500,000$1,250,000,000,000→ 11,000,000 total
    Exercise: $0.20From: 2014-12-12Exp: 2015-04-24→ Common Stock (2,500,000 underlying)
  • Purchase

    Convertible Note

    2015-01-30$2000000.00/sh+2,500,000$5,000,000,000,000→ 11,000,000 total
    Exercise: $0.20From: 2014-04-25Exp: 2019-12-17→ Common Stock (10,000,000 underlying)
  • Purchase

    Convertible Note

    2015-01-30$2000000.00/sh−2,500,000$5,000,000,000,000→ 11,000,000 total
    Exercise: $0.20From: 2014-04-25Exp: 2015-04-24→ Common Stock (10,000,000 underlying)
  • Purchase

    Convertible Note

    2015-03-12$2300000.00/sh+1,500,000$3,450,000,000,000→ 12,500,000 total
    Exercise: $0.20From: 2014-04-25Exp: 2019-12-17→ Common Stock (11,500,000 underlying)
Footnotes (3)
  • [F1]Advance of $500,000 under the previously disclosed $2,000,000 Secured Convertible Promissory Note resulting in total drawn principal of $2,000,000.
  • [F2]Amendment and restatement of the previously reported $2,000,000 Secured Convertible Promissory Note for the purpose of extending the contractual conversion to December 17, 2019 and revising the conversion rights such that the principal and the accrued interest may automatically convert at a purchase price per share equal to the lessor of $0.20 or the lowest price paid for new securities in a minimum $6,000,000 capital raise.
  • [F3]Amend and restatement of the previously reported $2,000,000 Secured Convertible Promissory Note for the purpose of increasing the principal of the note by $300,000 for a total of $2,300,000 and for advancing the $300,000.

Documents

1 file

Issuer

OMNI BIO PHARMACEUTICAL, INC.

CIK 0001389870

→
Entity typeoperating
IncorporatedCO

Related Parties

1
  • filerCIK 0001389870

Filing Metadata

Form type
4
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 6:10 PM ET
Size
13.0 KB
View on SEC.gov